KEYWORDS Diabetes mellitus; albuminuria; diabetic nephropathies; mass screening; angiotensin-converting enzyme inhibitors
For example, in non-African American patients, thiazide diuretics, calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors
are first-line treatments (Table 3).
Angioedema induced by angiotensin-converting enzyme inhibitors
Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors
Patients in the placebo group were unable to receive an angiotensin-converting enzyme inhibitor
during the study.
Reinecke, "Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors
or AT-1 blockers on frequency of contrast medium-induced nephropathy: a posthoc analysis from the Dialysis-versus-Diuresis (DVD) trial," Nephrology Dialysis Transplantation, vol.
One of the four guideline recommendations speaking to this issue is that the ACP "recommends against testing for proteinuria in adults with or without diabetes who are currently taking an angiotensin-converting enzyme inhibitor
or an angiotensin II-receptor blocker.
Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor
Adults assigned to drugs alone were prescribed similar treatments, which included aspirin, a statin, a [beta]-blocker, and an angiotensin-converting enzyme inhibitor
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor
and a beta-blocker on blood pressure reduction.
The actual ingredients are an angiotensin-converting enzyme inhibitor
(ramipril 5 mg), a beta-blocker (atenolol 50 mg), a diuretic (hydrochlorothiazide 12.
Angiotensin-converting enzyme inhibitor
induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature.
Effect of the angiotensin-converting enzyme inhibitor
benazepril on the progression of chronic renal insufficiency.
Cardiorenal protective effects of yearlong antihypertensive therapy with a angiotensin-converting enzyme inhibitor
or a calcium channel blocker in spontaneously hypertensive rat.